or
forgot password

    • cancer clinical trials in bakersfield, CA

    • Study of Imprime PGG® in Combination With Cetuximab in Subjects With Recurrent or Progressive KRAS Wild Type Colorectal Cancer
    Comprehensive Blood and Cancer Center
    Bakersfield, California 93309
    Colorectal Cancer
    A Study to Assess Dolutegravir in HIV-infected Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.
    GSK Investigational Site
    Bakersfield, California 93309
    Infection, Human Immunodeficiency Virus
    A Study of MM-121 With Paclitaxel in Platinum Resistant/ Refractory Advanced Ovarian Cancers
    Comprehensive Blood and Cancer Center
    Bakersfield, California 93309
    Epithelial Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer
    A Study to Evaluate the Efficacy and Safety of GS-6624 Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma
    Comprehensive Blood and Cancer Center
    Bakersfield, California 93309
    Pancreatic Cancer
    Efficacy and Safety of GS-6624 With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma
    Comprehensive Blood and Cancer Center
    Bakersfield, California 93309
    Colorectal Cancer
    Morphotek Investigation in Colorectal Cancer: Research of MORAb-004 (MICRO)
    Comprehensive Blood and Cancer Center
    Bakersfield, California 93309
    Metastatic Colorectal Cancer, Colorectal Cancer
    A Study of Weekly Carfilzomib in Combination With Dexamethasone for Progressive Multiple Myeloma
    Comprehensive Blood and Cancer Center (CCBC)
    Bakersfield, California
    Multiple Myeloma
    Phase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque Psoriasis
    Bakersfield Dermatology and Skin Cancer Medical Group
    Bakersfield, California 93309
    Psoriasis, Psoriatic Arthritis
    Belimumab Assessment of Safety in SLE
    GSK Investigational Site
    Bakersfield, California 93309
    Systemic Lupus Erythematosus
    Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
    Site Reference ID/Investigator# 61423
    Bakersfield, California 93309
    Hidradenitis Suppurativa
    Chemotherapy With or Without Immunotherapy in Treating Patients With Stage III or Stage IV Melanoma
    Comprehensive Blood and Cancer Center
    Bakersfield, California 93309
    Stage IV Melanoma, Stage III Melanoma, Recurrent Melanoma
    Irinotecan in Treating Patients With Esophageal or Stomach Cancer
    Comprehensive Blood and Cancer Center
    Bakersfield, California 93309
    Esophageal Cancer, Gastric Cancer
    The Study Of An Oral Drug Called A Radiation Sensitizer In Patients With Newly Diagnosed Small Cell Lung Cancer (SCLC)
    GSK Investigational Site
    Bakersfield, California 93309
    Lung Cancer, Small Cell, Small Cell Lung Cancer
    GW572016, An Oral Drug For Women With Refractory Metastatic Breast Cancer After First-line Or Second-line Herceptin
    GSK Investigational Site
    Bakersfield, California 93309
    Metastatic Breast Cancer
    Phase II Trial of Allovectin-7® for Metastatic Melanoma
    Comprehensive Blood and Cancer Center
    Bakersfield, California 93309
    Melanoma, Metastatic Melanoma, Malignant Melanoma, Skin Cancer
    Proleukin in Combination With Rituxan in Patients With Low-Grade Non-Hodgkin's Lymphoma Who Have Previously Failed Rituxan Treatments
    Comprehensive Blood and Cancer Center
    Bakersfield, California 93309
    Lymphoma, Non-Hodgkin
    Prialt (Ziconotide) In Severe Chronic Pain
    Advanced Pain Medicine
    Bakersfield, California 93311
    Pain
    Oral Drug Study In Women With Refractory Metastatic Breast Cancer After First-line or Second-line Herceptin.
    GSK Investigational Site
    Bakersfield, California 93309
    Metastatic Breast Cancer, Neoplasms, Breast
    A Study of Cetuximab in Patients Who Have Stage IV Colorectal Cancer
    ImClone Investigational Site
    Bakersfield, California 93309
    Colorectal Neoplasms
    Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal Cancer
    Comprehensive Blood and Cancer Center
    Bakersfield, California 93309
    Colorectal Neoplasms, Colonic Neoplasms, Rectal Neoplasms
    Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer.
    Comprehensive Blood and Cancer Center
    Bakersfield, California 93309
    Colorectal Neoplasms, Colonic Neoplasms, Rectal Neoplasms
    Second-line Intravenous Treatment For Recurrent Platinum-Sensitive Ovarian, Fallopian, Or Peritoneal Cancer
    GSK Investigational Site
    Bakersfield, California 93309
    Peritoneal Cancer, Ovarian Cancer, Neoplasms, Ovarian, Fallopian Tube Cancer
    Comparison of IV Topotecan/Docetaxel to Docetaxel Alone in Second-Line Stage IIIB/IV Non-Small Cell Lung Cancer
    GSK Investigational Site
    Bakersfield, California 93309
    Non-Small-Cell Lung Cancer, Lung Cancer, Non-Small Cell
    A Study Of Oral GW572016 In Advanced Or Metastatic Non-Small Cell Lung Cancer
    GSK Investigational Site
    Bakersfield, California 93309
    Non-Small-Cell Lung Cancer, Lung Cancer, Non-Small Cell
    Erbitux (Cetuximab) Given Alone to Patients With EGFR-Negative Metastatic Colon or Rectal Cancer That is Refractory to Chemotherapy
    ImClone Investigational Site
    Bakersfield, California 93309
    Colorectal Neoplasms, Metastases, Neoplasm
    Melphalan, Arsenic Trioxide, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma
    Comprehensive Blood and Cancer Center
    Bakersfield, California 93309
    Stage II Multiple Myeloma, Stage III Multiple Myeloma, Refractory Plasma Cell Neoplasm
    Dose-Escalation Study Of SB-485232 Administered As Daily Subcutaneous Injections In Adults With Solid Tumors
    GSK Investigational Site
    Bakersfield, California 93309
    Solid Tumor Cancer
    A Study to Evaluate Bevacizumab and Chemotherapy or Tarceva in Treating Recurrent or Refractory NSCLC (Non-Small Cell Lung Cancer)
    Comprehensive Blood and Cancer Center (TORI)
    Bakersfield, California 93309
    Non-Small-Cell Lung Carcinoma, Neoplasm Recurrence, Local
    A Study to Evaluate Psoriasis Outcomes and Safety Events in Patients With Chronic Moderate to Severe Plaque Psoriasis (RESPONSE)
    Bakersfield Dermatology and Skin Cancer Medical Grp
    Bakersfield, California 93309
    Psoriasis
    Trial of Carboplatin/Paclitaxel/Cetuximab in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)
    ImClone Investigational Site
    Bakersfield, California 93309
    Non-small Cell Lung Cancer
    Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
    GSK Investigational Site
    Bakersfield, California 93309
    Constipation, Bowel Dysfunction
    Alternative Dosing Regimens of Subcutaneous Azacitidine for Myelodysplastic Syndromes
    Comprehensive Blood and Cancer Center, Research Department
    Bakersfield, California 93309
    Myelodysplastic Syndromes
    SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adult Cancer Patients Receiving Chemotherapy
    GSK Investigational Site
    Bakersfield, California 93309
    Thrombocytopenia, Thrombocytopaenia
    A Multiple Myeloma Trial in Patients With Bone Metastases
    Comprehensive Blood and Cancer Center
    Bakersfield, California 93309
    Multiple Myeloma
    Study Of Prevention of Chemo-Induced Nausea and Vomiting Caused By Moderately Emetogenic Chemotherapy
    GSK Investigational Site
    Bakersfield, California 93309
    Nausea and Vomiting, Chemotherapy-Induced, Chemotherapy-Induced Nausea and Vomiting
    Anti-Tumor Activity Of SB-485232 In Patients With Previously Untreated Metastatic Melanoma
    GSK Investigational Site
    Bakersfield, California 93309
    Metastatic Melanoma
    Study of AS1404 With Docetaxel in Patients With Hormone Refractory Metastatic Prostate Cancer
    Comprehensive Blood and Cancer Center
    Bakersfield, California 93309
    Prostate Cancer
    Follow-up Study of GSK Biologicals' Human Papilloma Virus (HPV) Vaccine to Prevent Cervical Infection in Young Adults
    GSK Investigational Site
    Bakersfield, California 93309
    Papillomavirus Infection
    Human Papilloma Virus (HPV) Vaccine Efficacy Trial Against Cervical Pre-cancer in Young Adults With GlaxoSmithKline (GSK) Biologicals HPV-16/18
    GSK Investigational Site
    Bakersfield, California 93309
    Human Papillomavirus (HPV) Infection, Cervical Neoplasia
    Study 767905/008 Extension Study: Alvimopan for Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
    GSK Investigational Site
    Bakersfield, California 93309
    Cancer, Bowel Dysfunction
    Community Based Trial for AMEVIVE®
    Bakersfield Dermatology & Skin Cancer Medical Group
    Bakersfield, California 93301
    Moderate to Severe Chronic Plaque Psoriasis
    Treatment of Prostate Cancer With Adjuvant Bevacizumab Plus Erlotinib
    Comprehensive Blood and Cancer Center
    Bakersfield, California 93309
    Prostate Cancer
    Effects Of Lapatinib (GW572016) In Patients With Relapsed Adenocarcinoma Of The Esophagus
    GSK Investigational Site
    Bakersfield, California 93309
    Adenocarcinoma
    Placebo Controlled, Randomized Safety and Efficacy Study of RC-1291 in Cancer Anorexia/Cachexia.
    Comprehensive Blood & Cancer Center
    Bakersfield, California 93309
    Cancer Cachexia
    Intravenous Weekly Topotecan In Subjects With Recurrent Or Persistent Endometrial Cancer
    GSK Investigational Site
    Bakersfield, California 93309
    Neoplasms, Endometrial, Endometrial Cancer
    A Survival Study for Women With Advanced Lung Cancer Who Have Not Previously Received Chemotherapy.
    Comprehensive Blood and Cancer Center
    Bakersfield, California 93309
    NSCLC
    Erlotinib (Tarceva) as a Single Agent or Intercalated With Combination Chemotherapy in Patients With EGFR Positive NSCLC
    Comprehensive Blood and Cancer Center(Part of TORI network)
    Bakersfield, California 93309
    Carcinoma, Non-Small-Cell Lung
    Study of VELCADE and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
    Comprehensive Blood and Cancer Center
    Bakersfield, California 93309
    Non-Hodgkin's Lymphoma
    Second-Line Therapy Study For Potentially Platinum-Sensitive Relapsed Ovarian Cancer
    GSK Investigational Site
    Bakersfield, California 93309
    Ovarian Cancer, Neoplasms, Ovarian
    First-line Treatment Of Subjects With Extensive Disease Small Cell Lung Cancer With Weekly Hycamtin And Paraplatin
    GSK Investigational Site
    Bakersfield, California 93309
    Small Cell Lung Cancer
    Cetuximab and Bevacizumab With or Without Gemcitabine to Treat Metastatic Pancreatic Cancer
    ImClone Investigational Site
    Bakersfield, California 93309
    Metastatic Pancreatic Cancer
    Effects Of Prednisolone On Rheumatoid Arthritis Patients
    GSK Investigational Site
    Bakersfield, California 93309
    Arthritis, Rheumatoid
    Dose Finding Study Of Oral Eltrombopag In Patients With Sarcoma Receiving Adriamycin And Ifosfamide
    GSK Investigational Site
    Bakersfield, California 93309
    Sarcoma, Thrombocytopenia, Thrombocytopaenia, Thrombopoiesis
    Assessment Of Dutasteride (AVODART) In Extending The Time To Progression Of Low-Risk, Localized Prostate Cancer In Men
    GSK Investigational Site
    Bakersfield, California 93309
    Neoplasms, Prostate, Prostate Cancer
    Pazopanib As Pre-Surgical Therapy In Treatment-Naive Subjects With Non-Small Cell Lung Cancer
    GSK Investigational Site
    Bakersfield, California 93309
    Non-Small Cell Lung Cancer, Lung Cancer, Non-Small Cell
    Evaluation of Safety and Immunogenicity of Co-administering HPV Vaccine With Other Vaccines in Healthy Female Subjects
    GSK Investigational Site
    Bakersfield, California 93309
    Human Papillomavirus Type-16/-18 Infection, Papillomavirus Vaccines, Cervical Neoplasia
    A Phase I Study of Pazopanib in Adult Patients With Liver Cancer
    GSK Investigational Site
    Bakersfield, California 93309
    Carcinoma, Hepatic Cell, Liver Cancer
    Pazopanib Plus Lapatinib Compared to Lapatinib Alone and Pazopanib Alone In Subjects With Metastatic Cervical Cancer
    GSK Investigational Site
    Bakersfield, California 93309
    Neoplasms, Uterine Cervix, Metastatic Cervical Cancer
    Study of AKR-501 Tablets Taken Orally Once Daily for 28 Days in Patients With Chronic Idiopathic Thrombocytopenic Purpura (ITP)
    Comprehensive Blood and Cancer Center
    Bakersfield, California 93309
    Chronic Idiopathic Thrombocytopenic Purpura, Purpura, Thrombocytopenic, Idiopathic
    A Phase 1 Study Investigating the Combination of RAD001, Cetuximab and Irinotecan as Second-line Therapy After FOLFOX (or XELOX) Plus Bevacizumab in Patients With Metastatic Colorectal Cancer
    Comprehensive nBlood and Cancer Care
    Bakersfield, California 93309
    Colorectal Cancer, Colorectal Carcinoma, Colorectal Tumors, Neoplasms, Colorectal
    Lapatinib In Combination With Chemotherapy In Subjects With Relapsed Breast Cancer
    GSK Investigational Site
    Bakersfield, California 93309
    Relapsed Breast Cancer, Neoplasms, Breast